The trademark AMUNIX was filed by Amunix Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on January 16, 2022, and received one opposition filed on April 14, 2022 by Blue Earth Diagnostics Limited on Likelihood of confusion. the opponent was represented by SOCIETÀ ITALIANA BREVETTI S.P.A. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued April 14, 2022
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Protein polymeric intermediates for use in the manufacture of pharmaceutical preparations
Chemicals for use in the manufacture of pharmaceuticals
Biomedical compounds for use in pharmaceuticals.
The mark was filed in class 5 with following description of goods:
Pharmaceuticals
Pharmaceutical preparations and substances for use in oncology
Pharmaceutical preparations for the treatment of cancerous, inflammatory and viral diseases.
The mark was filed in class 42 with following description of goods:
Pharmaceutical research and development
Testing of pharmaceuticals
Pharmaceutical products development and evaluation